FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Civil rights groups file lawsuit seeking to block Texas law allowing cops to arrest illegal migrants

Rudy Giuliani’s primary care provider gives update on his condition

Police dog follows his nose to find missing autistic teen screaming for help

Ohio daycare worker convicted of horrific physical abuse of toddlers sentenced to years in prison

Alert: Child Struck by Gunfire as Secret Service Neutralizes Alleged Gunman Near White House

Staffer for Dem Sen. Cory Booker Who Brought Gun Into Capitol Without a License Saw Charges Quickly Dropped: DOJ

GOP challenger Joe Kaufman to run in Florida’s 25th district; will face either Moskowitz or Wasserman Schultz

Trump’s troop drawdown jolts Europe as NATO chief says leaders got the ‘message’

NATO Chief Says European Leaders Have Finally ‘Gotten the Message’ from Trump and Are Changing Their Ways

Woman objected to trans sex offender roommate — then she was sent back to prison, legal group says

Cassidy suggests governor boosted Trump-backed rival by not moving Senate primary

Report: Democrats Are Seeking to Stage a Mutiny Against the Chair of the DNC

Secret Service officers shoot armed individual near White House

Palisades Fire suspect was allegedly ‘fixated’ on Luigi Mangione and held ‘resentment of the rich’: court docs

Becerra and Hilton tied as California governor race tightens: Poll

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”